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Background: Worldwide particularly in developing countries, a large proportion of the population is at risk for
tropical parasitic diseases. Several medicinal plants are still used traditionally against protozoal infections in Yemen
and Saudi Arabia. Thus the present study investigated the in vitro antiprotozoal activity of twenty-five plants
collected from the Arabian Peninsula.
Methods: Plant materials were extracted with methanol and screened in vitro against erythrocytic schizonts of
Plasmodium falciparum, intracellular amastigotes of Leishmania infantum and Trypanosoma cruzi and free
trypomastigotes of T. brucei. Cytotoxic activity was determined against MRC-5 cells to assess selectivity. The criterion
for activity was an IC50 < 10 μg/ml (<5 μg/ml for T. brucei) and selectivity index of >4.
Results: Antiplasmodial activity was found in the extracts of Chrozophora oblongifolia, Ficus ingens, Lavandula
dentata and Plectranthus barbatus. Amastigotes of T. cruzi were affected by Grewia erythraea, L. dentata, Tagetes
minuta and Vernonia leopoldii. Activity against T. brucei was obtained in G. erythraea, L. dentata, P. barbatus and T.
minuta. No relevant activity was found against L. infantum. High levels of cytotoxicity (MRC-5 IC50 < 10 μg/ml) and
hence non-specific activities were noted in Cupressus sempervirens, Kanahia laniflora and Kniphofia sumarae.
Conclusion: The results endorse that medicinal plants can be promising sources of natural products with
antiprotozoal activity potential. The results support to some extent the traditional uses of some plants for the
treatment of parasitic protozoal diseases.Background
Today over one billion people worldwide are at risk for
tropical diseases caused by parasitic organisms. The
World Health Organization (WHO) now classifies many
as neglected tropical diseases, having an enormous impact
on socioeconomic development and quality of life at all
levels particularly in developing countries [1]. At present, a
lot of research is committed to leishmaniasis, malaria,
Chagas disease and sleeping sickness, not only because they
are major killing diseases but also because disease control
becomes more difficult due to a number of factors that
limit the utility of current drugs in resource-poor settings,* Correspondence: rmothana@ksu.edu.sa; r_mothana@yahoo.com
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unrestricted use, distribution, and reproductiosuch as high cost, poor compliance, drug resistance, low ef-
ficacy and poor safety [2]. Hence, the search for new and
preferably cheap drugs needs to be continued [3].
Natural products are still major potential sources of in-
novative therapeutic agents for various conditions, includ-
ing infectious diseases as they represent an unmet source
of chemical diversity [4]. Indeed, several antiparasitic
drugs have been derived directly from natural sources,
such as quinine, artemisinin and atovaquone as antimalar-
ials and amphotericin B as antileishmanial drug.
It is estimated that two thirds of the world population
still rely on traditional medical remedies, mainly plants,
because of limited availability and affordability of pharma-
ceutical medicines [5]. This explains why a lot of current
research focuses on natural molecules and plant-derived
products as they can be sourced easily, are locally availablentral Ltd; licensee BioMed Central Ltd. This is an Open Access article distributed
tribution License (http://creativecommons.org/licenses/by/2.0), which permits
n in any medium, provided the original work is properly cited.
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use [6].
In this study, 25 plants were selected from the flora
of Yemen and Saudi Arabia, and subjected to a broad
panel of in vitro antiparasitic assays in an attempt to
identify plant species with a promising antiprotozoal
in vitro activity profile and could be subject for further










Mo-H02a Asclepiadaceae L Fo
Centaurea pseudosinaica Czerep. Mo-S11a Asteraceae L, T Fo
Chrozophora oblongifolia (Del.)
A.Juss. ex Spreng.
Mo-S02a Euphorbiacea L, S As
a
Costus arabicus L. Mo-S05a Zingiberaceae R Fo
Cupressus sempervirens L. Mo-S25a Cupressaceae L As
Dodonaea viscosa (L.) Jacq. Mo-T01a Sapindaceae L, S Fo
lax
Dorstenia barnimiana Schweinf. Mo-T09 Moraceae L, S Fo
Enicostemma verticillare
(Retz.) Baill.
Mo-I06a Gentianaceae L Fo
Ficus cordata ssp. Salicifolia 15133 Moraceae L, S Fo
in
Ficus ingens (Miq.) 15187 Moraceae L, S Fo
Ficus palmata Forssk 15163 Moraceae L, S Fo
Grewia erythraea Schweinf. Mo-S07a Tiliaceae L, S As
Iris albicans Lange Mo-I02a Iridaceae R Fo
Kanahia laniflora (Forsk.) R. Br. Mo-I19a Asclepiadaceae L, T Fo
Kniphofia sumarae Deflers Mo-I10a Liliaceae R Fo
Lavandula dentata L. Mo-I11a Labiatae L, F Fo
an
Leucas inflata Benth. Mo-I05a Labiatae L, F Fo
Pulicaria inuloides DC. Mo-M05a Asteraceae L, F Fo
Plectranthus barbatus Andr. 15732a Labiatae L, S Fo
in
Rhus retinorrhaea Steud. ex Oliv. Mo-T22a Anacardiaceae L Ge
Tagetes minuta L. YT-20a Asteraceae L, S As
Tarconanthus camphoratus L Mo-S15a Asteraceae L, T Fo
Teucrium yemense Deflers Mo-S17a Labiatae L, F Fo
Vernonia leopoldii Vatke Mo-T16a Asteraceae L, F Fo
F Flower, L Leaves, R Roots or rhizomes, S Stems, T Fruits.
a information has been taken from native people.
b Chandel S, Bagai U, 2010 [7].
c Al-Dubai and Al-Khulaidi (1996) [8].
d Atiqur-Rahman et al., (2004) [9].
e Mossa et al., (1987) [10].
f Ali et al., (2004) [11].
g Fleurentin and Pelt (1982) [12].
h Schopen (1983) [13].Methods
Plant materials
Twenty five plants (Table 1) were selected randomly
from different areas of Yemen and Saudi Arabia in
March and Jun 2008 and identified at the Pharmacog-
nosy Departments, Colleges of Pharmacy, King Saud and
Sana'a Universities, Saudi Arabia and Yemen. The plants
were selected mainly on the basis of their local medicinaladitional uses
antiseptic and for teeth pains, stimulant, diuretic and in treatment of
eumatism, gout, palsy, amenorrhea and malaria a,b
r diabetes, stomachic ulcer and smallpox a, c
r wounds and kidney diseases a
antiseptic for wounds, antimicrobial, cathartic, emetic and hypoglycemic
nd for hemorrhoids a, d
r cancers a
expectorant, astringent and for wounds, diarrhea, hemorrhoids a, c
r malaria, wounds and burns, gout , rheumatism and as anesthetic,
ative and tonic a, c, e, f,
r the treatment of fungal and skin diseases a, c
r diabetes a
r the treatment of filariasis, diarrheal infections, tuberculosis and oral
fections a, c
r Piles, diarrhea, and as diuretic a
r constipation and lungs and bladder diseases a, c
Diuretic and haemostatic and for kidney diseases a
r rheumatism and gout a
r tumors, skin diseases, scabies and itching a, c, h
r malaria a
r wounds, rheumatism, urine retention, and kidney stones and as
tiseptic a, d
r kidney diseases and tooth ache a
r wounds and as antiseptic a
r stomachache, nausea, gastritis, intestinal spasms, burns, wounds, sores,
sect bites, allergies, ringworms, infections, malaria and break fevers a, f
neral tonic and for painful joints a
antimicrobial, anthelmintic, diuretic, and antispasmodic agent a, f
r wounds and for urinary tract infections a
r kidney diseases, rheumatism and diabetes a, d
r cough, colic and skin diseases a, h
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departments. The botanical names, plant part used and
the traditional uses of the plants in the collected areas
are presented in Table 1.Extraction of plant materials
The air-dried and powdered plant material (50 g) was
extracted with 500 ml methanol (CH3OH) by using a Soxh-
let apparatus for 8 hours. The obtained methanol extract
was filtered and evaporated by using a rotatory evaporator
and freeze dryer. The dried extracts were stored at −20°C
until used. Stock solutions were prepared in 100% DMSO at
20 mg/ml just prior to screening.Reference drugs
For the different tests, appropriate reference drugs were
used as positive control: tamoxifen for MRC-5, chloro-
quine for P. falciparum, miltefosine for L. infantum,
benznidazole for T. cruzi and suramin for T. b. brucei.
All reference drugs were either obtained from the fine
chemical supplier Sigma or from WHO-TDR.Biological assays
The integrated panel of microbial screens and standard
screening methodologies were adopted as previously
described [14]. All assays were performed in triplicate
(first test in duplicate and a single independent repeat)
at the Laboratory of Microbiology, Parasitology and Hy-
giene at the University of Antwerp, Belgium. Plant
extracts were tested at 5 concentrations (64, 16, 4, 1 and
0.25 μg/ml) to establish a full dose-titration and deter-
mination of the IC50 (inhibitory concentration 50%). The
concentration of DMSO did not exceed 0.5%. The select-
ivity of action was assessed by simultaneous evaluation
of cytotoxicity on a fibroblast (MRC-5) cell line. The cri-
terion for activity was an IC50 < 10 μg/ml (< 5 μg/ml for
T. brucei) and a selectivity index of > 4.Antileishmanial activity
L.infantum MHOM/MA(BE)/67 amastigotes were col-
lected from the spleen of an infected donor hamster and
used to infect primary peritoneal mouse macrophages. To
determine in vitro antileishmanial activity, 3×104 macro-
phages were seeded in each well of a 96-well plate. After
2 days outgrowth, 5×105 amastigotes/well were added and
incubated for 2 h at 37°C. Pre-diluted plant extracts were
subsequently added and the plates were further incubated
for 5 days at 37°C and 5% CO2. Parasite burdens (mean
number of amastigotes/macrophage) were microscopically
assessed after Giemsa staining, and expressed as a percent-
age of the blank controls without plant extract.Antiplasmodial activity
Chloroquine-resistant P. falciparum 2/K 1-strain was cul-
tured in human erythrocytes O+ at 37°C under a low oxygen
atmosphere (3% O2, 4% CO2, and 93%N2) in RPMI-1640,
supplemented with 10% human serum. Infected human red
blood cells (200 μl, 1% parasitaemia, 2% haematocrit) were
added to each well and incubated for 72 h. After incubation,
test plates were frozen at −20°C. Parasite multiplication was
measured by the Malstat method [14,15].
Antitrypanosomal activity
Trypanosoma brucei Squib-427 strain (suramin-sensi-
tive) was cultured at 37°C and 5% CO2 in Hirumi-9
medium [16], supplemented with 10% fetal calf serum
(FCS). About 1.5 × 104 trypomastigotes/well were added
to each well and parasite growth was assessed after
72 h at 37°C by adding resazurin [17]. For Chagas dis-
ease, T. cruzi Tulahuen CL2 (benznidazole-sensitive)
was maintained on MRC-5 cells in minimal essential
medium (MEM) supplemented with 20 mM L-glutam-
ine, 16.5 mM sodium hydrogen carbonate and 5%
FCS. In the assay, 4 × 103 MRC-5 cells and 4 × 104
parasites were added to each well and after incubation
at 37°C for 7 days, parasite growth was assessed by
adding the β-galactosidase substrate chlorophenol red
β-D-galactopyranoside [18]. The color reaction was
read at 540 nm after 4 h and absorbance values were
expressed as a percentage of the blank controls.
Cytotoxicity assay
MRC-5 SV2 cells were cultivated in MEM, supplemented
with L-glutamine (20 mM), 16.5 mM sodium hydrogen car-
bonate and 5% FCS. For the assay, 104 MRC-5 cells/well
were seeded onto the test plates containing the pre-diluted
sample and incubated at 37°C and 5% CO2 for 72 h. Cell
viability was assessed fluorimetrically after 4 hours of
addition of resazurin. Fluorescence was measured (excitation
550 nm, emission 590 nm) and the results were expressed
as % reduction in cell viability compared to control.
Results
Crude methanol extracts from 25 plant species belong-
ing to 18 families that are used in Arabian traditional
medicine, were evaluated in the integrated in vitro
screen for antileishmanial, antiplasmodial and antitrypa-
nosomal potential (Table 2). Only 7 extracts exhibited
relevant activity (acceptable potency and selectivity) in
one or more models (Table 2).
Antimalarial activity
In this study, the methanol extract of Chrozophora oblongi-
folia exhibited the greatest activity against P. falciparum
with an IC50 value of 5.0 μg/ml and a high SI value of 12.8.
Furthermore, the extract of three other plants (Ficus ingens,
Table 2 Antiprotozoal activity of the methanol extracts of the investigated plants and their cytotoxicity against MRC-5
cell lines
Plant species P. falciparum L. infantum T. cruzi T. brucei MRC-5
IC50 SI IC50 SI IC50(μg/ml) SI IC50 SI IC50
Ajuga bracteosa >64.0 >1 >64.0 >1 28.8 ± 4.6 >2.22 31.2 ± 5.2 >2.05 >64.0
Caralluma quadrangula 27.5 ± 4.3 >2.33 >64.0 >1 >64.0 >1 32.5 ± 6.5 >1.97 >64.0
Centaurea pseudosinaica 48.2 ± 9.8 32.5 ± 3.5 31.0 ± 6.1 9.1 ± 1.8 1.76 16.0 ± 5.3
Chrozophora oblongifolia 5.0 ± 1.2 12.80 27.3 ± 2.8 2.34 32.0 ± 5.8 >2 10.8 ± 2.4 5.93 >64.0
Costus arabicus >64.0 27.3 ± 3.1 1.41 13.8 ± 2.1 2.79 30.0 ± 4.9 1.28 38.5 ± 8.2
Cupressus sempervirens 7.6 ± 2.4 1.41 2.0 ± 0.4 5.35 8.3 ± 1.9 1.29 2.1 ± 0.2 5.10 10.7 ± 3.1
Dorstenia barnimiana 34.2 ± 8.7 1.44 >64.0 29.6 ± 3.9 1.67 22.6 ± 5.8 2.19 49.4 ± 9.1
Dodonaea viscosa 46.7 ± 11.8 >1.37 45.3 ± 11.8 1.41 >64.0 >1 11.1 ± 1.8 5.77 >64.0
Enicostemma verticillare >64.0 ± >1 >64.0 >1 >64.0 >1 9.9 ± 1.1 >6.46 >64.0
Ficus cordata ssp.salicifolia 27.0 ± 6.9 1.20 27.3 ± 6.1 1.19 26.3 ± 3.2 1.24 8.2 ± 1.9 3.96 32.5 ± 7.3
Ficus ingens 8.4 ± 2.3 3.87 32.5 ± 7.2 1.00 31.2 ± 4.3 1.04 8.0 ± 2.2 4.06 32.5 ± 7.5
Ficus palmata 14.5 ± 3.8 2.60 >64.0 22.6 ± 4.0 1.67 8.1 ± 2.6 4.65 37.7 ± 6.9
Grewia erythraea 11.7 ± 3.5 2.32 24.1 ± 3.8 1.13 8.2 ± 1.8 3.32 2.6 ± 0.9 10.46 27.2 ± 6.1
Iris albicans 55.5 ± 6.2 >1.15 >64.0 >1 >64.0 >1 10.6 ± 3.1 >6.04 >64.0
Kanahia laniflora 27.9 ± 4.9 >64.0 0.4 ± 0.2 2.00 9.6 ± 3.0 0.8 ± 0.2
Kniphofia sumarae 1.3 ± 0.6 5.69 32.5 ± 4.9 31.4 ± 3.4 5.9 ± 2.8 1.25 7.4 ± 1.4
Lavandula dentata 7.1 ± 1.4 4.17 20.3 ± 3.5 1.46 7.9 ± 0.5 3.75 3.0 ± 1.8 9.87 29.6 ± 5.9
Leucas inflata 44.6 ± 6.3 >64.0 >64.0 8.4 ± 2.2 3.51 29.5 ± 6.0
Plectranthus barbatus 6.5 ± 2.0 5.06 24.1 ± 2.9 1.37 23.3 ± 2.9 1.41 2.6 ± 1.8 12.65 32.9 ± 6.8
Pulicaria inuloides 21.6 ± 3.8 >2.96 45.3 ± 8.3 1.41 31.7 ± 4.0 >2.02 7.8 ± 2.1 >8.21 >64.0
Rhus retinorrhaea 37.1 ± 4.9 1.43 >64.0 30.5 ± 3.9 1.74 34.0 ± 5.8 1.56 53.2 ± 7.2
Tagetes minuta 14.0 ± 2.8 4.57 30.1 ± 4.6 >2.13 9.2 ± 1.9 >6.96 2.2 ± 1.5 >29.09 >64.0
Tarconanthus camphoratus >64.0 >1 >64.0 >1 >64.0 >1 >64.0 >1 >64.0
Teucrium yemense 12.5 ± 2.6 2.18 32.5 ± 6.6 30.5 ± 2.9 7.1 ± 2.3 3.83 27.2 ± 5.3
Vernonia leopoldii 41.9 ± 7.9 27.3 ± 5.1 1.10 9.2 ± 1.2 3.27 8.0 ± 2.9 3.76 30.1 ± 4.9
Chloroquine 0.3 ± 0.1 - - - -
Miltefosine - 3.32 ± 0.7 - - -
Benznidazole - - 2.2 ± 0.5 - -
Suramin - - - 0.03 ± 0.02 -
Tamoxifen - - - - 11.0 ± 2.3
IC50 values of reference drugs are expressed in μM/ml concentrations.
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tivity against P. falciparum with IC50 8.4, 7.1 and 6.5 μg/ml
respectively. These extracts exhibited moderate SI values of
3.8, 4.1 and 5.1, respectively.Antileishmanial activity
No relevant results were found against L. infantum. A
very marginal activity was observed for C. oblongifolia,
Costus arabicus, Grewia erythraea, L. dentata, P. barba-
tus, and Vernonia leopoldii with IC50 values between
20.3 and 27.3 μg/ml and low SI values between 1.0
and 2.5.Antitrypanosomal activity
Our screen demonstrated that T. b. brucei is more sensitive
than T. cruzi towards the investigated plant extracts (Table 2).
The results revealed that the extract of G. erythraea showed
activity against T. cruzi (IC50 8.2 μg/ml) and T. brucei
(IC50 2.6 μg/ml). Additionally, L. dentata demonstrated
activity against T. cruzi and T. brucei with IC50 values of
7.9 and 3.0 μg/ml respectively. Meanwhile, the extract of
Tagetes minuta showed less activity against T. cruzi with
an IC50 value of 9.2 (SI = 6.9) and higher activity against
T. brucei with an IC50 value of 2.2 μg/ml and the highest
SI value of >29.1. On the other hand, the methanol extract
of P. barbatus, showed antitrypanosomal activity only
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while the extract of V. leopoldii showed activity against both
T. cruzi and T. brucei (IC50 9.2 and 8.0 μg/ml) with low SI
values of 3.2 and 3.7 respectively.
Cytotoxicity assay
The highest cytotoxic effect against MRC-5 cells was
obtained with the methanol extract of Kanahia laniflora
(IC50 of 0.83 μg/ml). The extracts of Kniphofia sumarae
and Cupressus sempervirens also exhibited a noticeable
cytotoxic effect with IC50 values of 7.7 and 10.7 μg/ml
respectively (Table 2).
Discussion
The scientific evaluation of medicinal plants used in the
preparation of folk remedies has provided modern medi-
cine with several effective pharmaceuticals for the treat-
ment of diseases caused by protozoan parasites [19,20].
As a result of this, during the last two decades numerous
studies from various parts of the world on antiprotozoal
activity of medicinal plants have been reported [21-26].
In continuation of our search for substances of plant ori-
gin with pharmacological effects, we have screened 25
plants collected from Saudi Arabia and Yemen for their
antiplasmodial, antileishmanial and antitrypanosomal ac-
tivities. It is important to mention that at the best of our
knowledge, this study represents the first report on anti-
protozoal activities for most part of the investigated plants.
Although few plants are partly investigated, existing know-
ledge remains in many cases very limited. Based on the ac-
tivity (IC50) and selectivity, seven plant extracts could be
considered as promising and interesting enough to engage
in further purification and evaluation.
During the course of screening, it was found that the
methanol extract of the C. oblongifolia, collected from
Yemen, exhibited the greatest antiplasmodial activity. Our
result is in agreement with data reported recently by
Abdel-Sattar et al. (2010) [27], which showed antiplasmo-
dial activity for this species collected from Saudi Arabia
(IC50 4.8 μg/ml) with a better selectivity (SI > 13.2). More-
over, Benoit-Vical et al. (2008) [28] reported that the water
extract of Chrozophora senegalensis showed a remarkable
in vitro antimalarial activity (IC50 1.6 μg/ml).
Other interesting and promising source of antiplasmo-
dial and antitrypanosomal activities is F. ingens. It is worth
to mention that this is the first report on the antiprotozoal
activity of F. ingens. Other Ficus species like F. citrifolia,
F. fistulosa, and F. sur demonstrated a noticeable antimal-
arial activity [29-31]. Moreover, bioassay-guided fraction-
ation of the extract from the dried leaves and stem barks
of F. fistulosa led to the isolation of trichothecene sesqui-
terpenoids, including verrucarin L acetate which was
found to inhibit the growth of P. falciparum with IC50
values below 1 ng/ml [30].Another interesting plant was G. erythraea, which
demonstrated considerable antimalarial and antitrypano-
somal activities. Our data are in agreement with litera-
ture data of other Grewia species such as G. hexaminta
and G. bilamellata [32,33]. Ma et al., (2006) [32] demon-
strated that some triterpenoids e.g. 3α,20-lupandiol, gre-
win, nitidanin and 2α,3β-dihydroxy-olean-12-en-28-oic
acid isolated from G. bilamellata are responsible for the
antimalarial effect and showed varying degrees of
in vitro activity against P. falciparum. The presence of
such terpenoids in our G. erythraea may explain the bio-
logical effects seen in our screen.
Moreover, one of the most interesting plants was L. dentata
collected from Yemen. Our antiparasitic screening revealed
remarkable in vitro antiplasmodial and antitrypanosomal
activity observed for L. dentata but with moderate SI of 4.1
and 9.8. These findings are in agreement with literature
data published recently by Abdel-Sattar et al. (2010) [27]
who reported the antiparasitic activity of the methanol ex-
tract of L. dentata growing in Saudi Arabia. The extract of
L. dentata growing in Saudi Arabia showed better selectiv-
ity for P. falciparum (SI = 32.1) as compared with our
results. This can be attributed to variation in the area of
collection and ecological factors, which has a great impact
on the quality and quantity of plants constituents. Appar-
ently the activity of this species is mostly attributed to the
presence of essential oil which was revealed to be respon-
sible for antiparasitic and antibacterial activities [34,35].
Tempone et al., (2008) [36] investigated the antileishma-
nial activity of some Brazilian flora extracts, including
P. barbatus which showed activity against L. chagasi with
EC50 value of 54.5 μg/ml. In earlier studies, several
Plectranthus species showed antiplasmodial activity against
P. falciparum 3D7 strain [37,38]. The results obtained in
the present screen are in agreement with the literature data
found and hence justifies the folkloric use. In addition to
that, Van Zyl et al., (2008) [38] attributed the antiplasmo-
dial activity of these Plectranthus species to the presence of
abietane diterpenes.
Whereas the crude extract of T. minuta showed a re-
markable antitrypanosomal activity against both trypano-
some species, no effect was found against P. falciparum.
Obviously our results of the antiplasmodial activity of
T. minuta were not in agreement with the antimalarial ef-
fect noted recently by Lacroix et al., (2011) and Shahzadi
et al., (2010) [39,40]. It was demonstrated that the ethyl
acetate as well as n-hexane extract exhibited a notable
antimalarial activity at 2.78 μg/ml against P. falciparum
3D7 strain. Apparently these findings are attributed to the
presence of essential oil as well as sesquiterpene lactones.
In our screen A. bracteosa didn't show any interesting
antiprotozoal activity. These results are not in agreement
with those recently reported by Chandel and Bagai
(2010) [7]. In contrast to several reports on Vernonia
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V. colorata indicating in vitro and in vivo antiplasmodial
activity [41-43], our extract of V. leopoldii showed no anti-
plsmodial activity. On the other hand,V. leopoldii showed
a notable antitrypanosomal activity, which was in agree-
ment with the results obtained by Hoet et al. (2004) [44]
who attributed the antitrypanosomal activity to the pres-
ence of stigmastane-type steroids e.g. vernoguinosterol
and vernoguinoside, which were isolated from the stem
bark of V. guineensis. Such compounds could also be re-
sponsible for the observed effect of V. leopoldii.
Conclusion
In conclusion, the results show that scientific studies
carried out on medicinal plants having traditional claims
of effectiveness can yield fruitful results. The present
work led to the identification of seven plant extracts
exhibiting relevant antiprotozoal potential namely C.
oblongifolia, F. ingens, G. erythraea, L. dentata, P. bar-
batus, T. minuta and V. leopoldii. Moreover, the results
in the present study support to some extent the trad-
itional uses of some plants for the treatment of parasitic
diseases. Studies aimed at the isolation and structure
elucidation of antiprotozoal active constituents from
some investigated plants are now in progress.
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